Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 18 stocks, with a combined market cap of $2,798.22 billion, total revenue of $604.19 billion and a weighted average PE ratio of 31.14.

Market Cap
2,798.22B
Revenue
604.19B
Profits
89.86B
PE Ratio
31.14
Profit Margin
14.87%
Dividend Yield
2.20%

18 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company689.18B-1.00%2,597,58234.12B
2JNJJohnson & Johnson353.80B-1.15%7,591,46685.16B
3MRKMerck & Co., Inc.331.07B2.93%12,739,81860.12B
4ABBVAbbVie Inc.296.21B-0.30%4,567,88454.32B
5AZNAstraZeneca PLC232.58B5.38%15,338,14647.61B
6NVSNovartis AG193.81B0.72%2,315,26949.92B
7AMGNAmgen Inc.144.37B-1.33%1,791,79028.19B
8PFEPfizer Inc.142.64B-3.84%47,041,42958.50B
9SNYSanofi119.44B5.90%6,469,54851.60B
10BMYBristol-Myers Squibb Company90.60B-8.51%42,293,48145.53B
11GSKGSK plc83.01B0.12%3,015,24338.39B
12GILDGilead Sciences, Inc.81.39B-2.70%13,967,55627.12B
13BIIBBiogen Inc.29.43B0.23%1,589,4719.66B
14GRFSGrifols, S.A.5.48B-1.88%1,012,1137.32B
15OGNOrganon & Co.4.71B-1.55%1,449,5596.26B
16AMRNAmarin Corporation plc351.63M-2.11%711,790306.91M
17SCLXScilex Holding Company143.06M1.27%726,93546.74M
18MIRAMIRA Pharmaceuticals, Inc.13.30M3.45%20,404-